EGFR and non-small cell lung carcinoma: In contrast, this study, utilizing real-world patient tissue and blood samples, provides the evidence that patients with EGFR-mutant NSCLC exhibiting high PD-L1 expression also display a higher proportion of CD56bright NK cells for the first time.